Scientists reprogram cancer cells with low doses of epigenetic drugs
Friday, March 23, 2012 - 00:40
in Biology & Nature
Experimenting with cells in culture, researchers have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.